Finzati - Logo
NUTX logo

Nutex Health, Inc.

NUTX • Medical - Care Facilities
$193.24
▼ -4.44 (-2.25%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHLY FAVORABLE PROFILEExcellentConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$1.05B
Growth
50.8%
Cash Flow
4/5
Trend
Mostly stable
Evidence
Stable or improving margins · 8.1%Positive revenue growth · 13.6%Positive free cash flow · 38.61Consistent free cash flow · 4/5Reasonable earnings multiple · 14.79
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 1:14 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$193.24
Change-2.25%
Market Cap$1.05B
52W Range77.21 - 204.00
Beta1.97
Gross Margin50.76%
Oper. Margin31.49%
Profit Margin8.09%
Debt/Eq1.07
Current Ratio3.41
Quick Ratio3.39
Revenue 5Y50.84%

Investment DNA

How strong this company looks for long-term investors

82
out of 100
Business Quality
Margins, moat, returns
72/100
Financial Strength
Debt, cash, stability
87/100
Growth Potential
Revenue and expansion
76/100
Price Attractiveness
Cheap or expensive today
88/100
Why this score▼
Stable or improving margins · 8.1%Positive revenue growth · 13.6%Positive free cash flow · 38.61Consistent free cash flow · 4/5Reasonable earnings multiple · 14.79Healthy liquidity · 3.41

Analyst view

Analyst sentiment and price target

Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-07
Low
$235.00
Mean
$235.00
Median
$235.00
High
$235.00

Company Overview

IPO: 4/4/2022
Industry: Medical - Care Facilities
P/B i: 3.18
Debt / Equity i: 1.07
Operating Margin: 31.49%
Net Margin: 8.09%
ROE i: -
ROIC: -

Financial Health

Score17 / 20
Debt / Equity: 1.07
Current Ratio: 3.41
Quick Ratio: 3.39
Status: Strong

Insider Transactions

Recent executive and insider activity

Reed Michael Lee
Transaction: 07/31/2026
BUY
Change
+603
Price
Not reported
Filing
08/03/2026
Type
BUY
Saunders Scott J
Transaction: 07/31/2026
BUY
Change
+603
Price
Not reported
Filing
08/03/2026
Type
BUY
Grenas Cheryl Yvonne
Transaction: 07/31/2026
BUY
Change
+603
Price
Not reported
Filing
08/03/2026
Type
BUY